DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)

CUSIP: 25253X207

Q2 2021 13F Holders as of 30 Jun 2021

Holder snapshot 7 signals
Share change
-1,910,088
Put/Call ratio
714%
SEC-reported price per share
$4.45
Number of holders
38
Value change
-$48,644,584
Number of buys
21
Open additional details 1 more signal available
Number of sells
16
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
52,272,727

Security key

25253X207

Report period

Q2 2021

Institutions

38

Top holders

10

Ownership snapshot

Top reported holders of DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Dorsey Wright & Associates
Disclosed value leader
Dorsey Wright & Associates
Comparable rows
0/15
Latest evidence
31 Mar 2021
13F Highest disclosed value: $36,024,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Dorsey Wright & Associates has the largest disclosed position value at $36.02M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Dorsey Wright & Associates's linked filing trail.
Disclosed position value Top 5
Dorsey Wright & Associates $36.02M
Stonepine Capital Management, LLC $9.36M
Corriente Advisors, LLC $7.96M
VANGUARD GROUP INC $7.74M
Manatuck Hill Partners, LLC $5.22M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Dorsey Wright & Associates
13F
Company
13F
—
denominator unverified
$36,024,000
3,937 shares
— 31 Mar 2021
Stonepine Capital Management, LLC
13F
Company
13F
—
denominator unverified
$9,364,000
1,023,409 shares
— 31 Mar 2021
Corriente Advisors, LLC
13F
Company
13F
—
denominator unverified
$7,963,000
870,228 shares
— 31 Mar 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$7,744,000
846,266 shares
— 31 Mar 2021
Manatuck Hill Partners, LLC
13F
Company
13F
—
denominator unverified
$5,220,000
570,500 shares
— 31 Mar 2021
Point72 Asset Management, L.P.
13F
Company
13F
—
denominator unverified
$5,053,000
552,250 shares
— 31 Mar 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
38
Shares
3,783,974
Rows available
38
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
38
Q2 2021 holders
38
Holder diff
0
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 value Q2 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .